Clinical Trial Update: A Phase I Study of E7050 in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

This document provides an update on a Phase I study of the investigational agent E7050 in subjects with solid tumors, including gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• E7050

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Solid Tumor, Gastric Cancer | Phase 1 | Status: COMPLETED